
Pharming Group (PHAR) Earnings Dates & Reports
Pharming Group (PHAR) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS$0.07
Actual EPS$0.07
EarningsMeet
Pharming Group (PHAR) Earnings
View the latest Pharming Group (PHAR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Pharming Group (PHAR)
Order type
Buy in
Order amount
Est. shares
0 shares
Pharming Group (PHAR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Pharming Group (PHAR) Latest Earnings
The value each PHAR share was expected to gain vs. the value each share gained.
Pharming Group (PHAR) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of $0.07. This exceeded analysts' expectations of $0.07 by 0.00%, marking a Meet.
For comparison, Pharming Group reported EPS of $0.05 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Pharming Group (PHAR) Earnings History
Pharming Group (PHAR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Pharming Group’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Pharming Group (PHAR) Earnings FAQs
Pharming Group (PHAR) last reported earnings on Mar 12, 2026 for Q4 2025, posting an EPS of $0.07, which Meet the estimate of $0.07 by 0.00%.
For Q4 2025, Pharming Group (PHAR) reported an EPS of $0.07, missing analysts' estimate of $0.07 by 0.00%.
For Q4 2025, Pharming Group (PHAR) Meet expectations with an actual EPS of $0.07 vs. an estimated EPS of $0.07.
Following the last earnings report on Mar 12, 2026, Pharming Group (PHAR)'s stock price moved — from — to —.
The next Pharming Group (PHAR) earnings call is scheduled for May. 7, 2026, where executives will discuss financial results and outlook.